Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines.

Berardocco M, Radeghieri A, Busatto S, Gallorini M, Raggi C, Gissi C, D'Agnano I, Bergese P, Felsani A, Berardi AC.

Oncotarget. 2017 Aug 24;8(47):82920-82939. doi: 10.18632/oncotarget.20503. eCollection 2017 Oct 10.

2.

A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma.

Megiorni F, Colaiacovo M, Cialfi S, McDowell HP, Guffanti A, Camero S, Felsani A, Losty PD, Pizer B, Shukla R, Cappelli C, Ferrara E, Pizzuti A, Moles A, Dominici C.

Oncol Rep. 2017 Jul;38(1):3-20. doi: 10.3892/or.2017.5701. Epub 2017 Jun 6.

3.

Correction: PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.

Cenciarelli C, Marei HE, Felsani A, Casalbore P, Sica G, Puglisi MA, Cameron AJ, Olivi A, Mangiola A.

Oncotarget. 2017 May 30;8(22):36931. doi: 10.18632/oncotarget.18268. No abstract available.

4.

The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.

Cenciarelli C, Marei HE, Zonfrillo M, Casalbore P, Felsani A, Giannetti S, Trevisi G, Althani A, Mangiola A.

Oncotarget. 2017 Mar 14;8(11):17873-17886. doi: 10.18632/oncotarget.15013.

5.

PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.

Cenciarelli C, Marei HE, Felsani A, Casalbore P, Sica G, Puglisi MA, Cameron AJ, Olivi A, Mangiola A.

Oncotarget. 2016 Aug 16;7(33):53047-53063. doi: 10.18632/oncotarget.10132. Erratum in: Oncotarget. 2017 May 30;8(22):36931.

6.

Lamin A/C Is Required for ChAT-Dependent Neuroblastoma Differentiation.

Guglielmi L, Nardella M, Musa C, Iannetti I, Arisi I, D'Onofrio M, Storti A, Valentini A, Cacci E, Biagioni S, Augusti-Tocco G, D'Agnano I, Felsani A.

Mol Neurobiol. 2017 Jul;54(5):3729-3744. doi: 10.1007/s12035-016-9902-6. Epub 2016 May 25.

PMID:
27221609
7.

Histone Modifications in a Mouse Model of Early Adversities and Panic Disorder: Role for Asic1 and Neurodevelopmental Genes.

Cittaro D, Lampis V, Luchetti A, Coccurello R, Guffanti A, Felsani A, Moles A, Stupka E, D' Amato FR, Battaglia M.

Sci Rep. 2016 Apr 28;6:25131. doi: 10.1038/srep25131.

8.

Regulation of nucleus accumbens transcript levels in mice by early-life social stress and cocaine.

Lo Iacono L, Valzania A, Visco-Comandini F, Viscomi MT, Felsani A, Puglisi-Allegra S, Carola V.

Neuropharmacology. 2016 Apr;103:183-94. doi: 10.1016/j.neuropharm.2015.12.011. Epub 2015 Dec 17.

PMID:
26706499
9.

Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells.

Nardella M, Guglielmi L, Musa C, Iannetti I, Maresca G, Amendola D, Porru M, Carico E, Sessa G, Camerlingo R, Dominici C, Megiorni F, Milan M, Bearzi C, Rizzi R, Pirozzi G, Leonetti C, Bucci B, Mercanti D, Felsani A, D'Agnano I.

Oncotarget. 2015 Oct 20;6(32):32821-40. doi: 10.18632/oncotarget.5104.

10.

The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.

Fazi B, Felsani A, Grassi L, Moles A, D'Andrea D, Toschi N, Sicari D, De Bonis P, Anile C, Guerrisi MG, Luca E, Farace MG, Maira G, Ciafré SA, Mangiola A.

Oncotarget. 2015 Sep 8;6(26):22526-52.

11.

Brahma is required for cell cycle arrest and late muscle gene expression during skeletal myogenesis.

Albini S, Coutinho Toto P, Dall'Agnese A, Malecova B, Cenciarelli C, Felsani A, Caruso M, Bultman SJ, Puri PL.

EMBO Rep. 2015 Aug;16(8):1037-50. doi: 10.15252/embr.201540159. Epub 2015 Jul 1.

12.

Early handling and repeated cross-fostering have opposite effect on mouse emotionality.

Luchetti A, Oddi D, Lampis V, Centofante E, Felsani A, Battaglia M, D'Amato FR.

Front Behav Neurosci. 2015 Apr 21;9:93. doi: 10.3389/fnbeh.2015.00093. eCollection 2015.

13.

Signaling by exosomal microRNAs in cancer.

Falcone G, Felsani A, D'Agnano I.

J Exp Clin Cancer Res. 2015 Apr 2;34:32. doi: 10.1186/s13046-015-0148-3. Review.

14.

When chocolate seeking becomes compulsion: gene-environment interplay.

Patrono E, Di Segni M, Patella L, Andolina D, Valzania A, Latagliata EC, Felsani A, Pompili A, Gasbarri A, Puglisi-Allegra S, Ventura R.

PLoS One. 2015 Mar 17;10(3):e0120191. doi: 10.1371/journal.pone.0120191. eCollection 2015.

15.

Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members.

Megiorni F, Cialfi S, McDowell HP, Felsani A, Camero S, Guffanti A, Pizer B, Clerico A, De Grazia A, Pizzuti A, Moles A, Dominici C.

BMC Cancer. 2014 Nov 25;14:880. doi: 10.1186/1471-2407-14-880.

16.

PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.

Cenciarelli C, Marei HE, Zonfrillo M, Pierimarchi P, Paldino E, Casalbore P, Felsani A, Vescovi AL, Maira G, Mangiola A.

Mol Cancer. 2014 Nov 8;13:247. doi: 10.1186/1476-4598-13-247.

17.

Impact of different ChIP-Seq protocols on DNA integrity and quality of bioinformatics analysis results.

Felsani A, Gudmundsson B, Nanni S, Brini E, Moles A, Thormar HG, Estibeiro P, Gaetano C, Capogrossi M, Farsetti A, Jonsson JJ, Guffanti A.

Brief Funct Genomics. 2015 Mar;14(2):156-62. doi: 10.1093/bfgp/elu001. Epub 2014 Feb 21.

PMID:
24562761
18.

MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells.

Guglielmi L, Cinnella C, Nardella M, Maresca G, Valentini A, Mercanti D, Felsani A, D'Agnano I.

Cell Death Dis. 2014 Feb 20;5:e1081. doi: 10.1038/cddis.2014.42.

19.

Identification of pivotal cellular factors involved in HPV-induced dysplastic and neoplastic cervical pathologies.

Mattarocci S, Abbruzzese C, Mileo AM, Carosi M, Pescarmona E, Vico C, Federico A, Vizza E, Corrado G, Arisi I, Felsani A, Paggi MG.

J Cell Physiol. 2014 Apr;229(4):463-70. doi: 10.1002/jcp.24465.

PMID:
24105779
20.

The role of CDX2 in Caco-2 cell differentiation.

Natoli M, Christensen J, El-Gebali S, Felsani A, Anderle P.

Eur J Pharm Biopharm. 2013 Sep;85(1):20-5. doi: 10.1016/j.ejpb.2013.03.018.

PMID:
23958315
21.

Characterization of the genome of the dairy Lactobacillus helveticus bacteriophage {Phi}AQ113.

Zago M, Scaltriti E, Rossetti L, Guffanti A, Armiento A, Fornasari ME, Grolli S, Carminati D, Brini E, Pavan P, Felsani A, D'Urzo A, Moles A, Claude JB, Grandori R, Ramoni R, Giraffa G.

Appl Environ Microbiol. 2013 Aug;79(15):4712-8. doi: 10.1128/AEM.00620-13. Epub 2013 May 31.

22.

Estrogen-dependent dynamic profile of eNOS-DNA associations in prostate cancer.

Nanni S, Aiello A, Re A, Guffanti A, Benvenuti V, Colussi C, Castro-Vega LJ, Felsani A, Londono-Vallejo A, Capogrossi MC, Bacchetti S, Gaetano C, Pontecorvi A, Farsetti A.

PLoS One. 2013 May 3;8(5):e62522. doi: 10.1371/journal.pone.0062522. Print 2013.

23.

LMNA knock-down affects differentiation and progression of human neuroblastoma cells.

Maresca G, Natoli M, Nardella M, Arisi I, Trisciuoglio D, Desideri M, Brandi R, D'Aguanno S, Nicotra MR, D'Onofrio M, Urbani A, Natali PG, Del Bufalo D, Felsani A, D'Agnano I.

PLoS One. 2012;7(9):e45513. doi: 10.1371/journal.pone.0045513. Epub 2012 Sep 26.

24.

Defining new criteria for selection of cell-based intestinal models using publicly available databases.

Christensen J, El-Gebali S, Natoli M, Sengstag T, Delorenzi M, Bentz S, Bouzourene H, Rumbo M, Felsani A, Siissalo S, Hirvonen J, Vila MR, Saletti P, Aguet M, Anderle P.

BMC Genomics. 2012 Jun 22;13:274. doi: 10.1186/1471-2164-13-274.

25.

Contribution of serine racemase/d-serine pathway to neuronal apoptosis.

Esposito S, Pristerà A, Maresca G, Cavallaro S, Felsani A, Florenzano F, Manni L, Ciotti MT, Pollegioni L, Borsello T, Canu N.

Aging Cell. 2012 Aug;11(4):588-98. doi: 10.1111/j.1474-9726.2012.00822.x. Epub 2012 Jun 5.

26.

Good Caco-2 cell culture practices.

Natoli M, Leoni BD, D'Agnano I, Zucco F, Felsani A.

Toxicol In Vitro. 2012 Dec;26(8):1243-6. doi: 10.1016/j.tiv.2012.03.009. Epub 2012 Mar 23.

PMID:
22465559
27.

Differentiation of Caco-2 cells requires both transcriptional and post-translational down-regulation of Myc.

Leoni BD, Natoli M, Nardella M, Bucci B, Zucco F, D'Agnano I, Felsani A.

Differentiation. 2012 Mar;83(3):116-27. doi: 10.1016/j.diff.2011.10.005. Epub 2011 Nov 20.

PMID:
22364879
28.

Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs.

Voellenkle C, Rooij Jv, Guffanti A, Brini E, Fasanaro P, Isaia E, Croft L, David M, Capogrossi MC, Moles A, Felsani A, Martelli F.

RNA. 2012 Mar;18(3):472-84. doi: 10.1261/rna.027615.111. Epub 2012 Jan 26.

29.

Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas.

Abbruzzese C, Mattarocci S, Pizzuti L, Mileo AM, Visca P, Antoniani B, Alessandrini G, Facciolo F, Amato R, D'Antona L, Rinaldi M, Felsani A, Perrotti N, Paggi MG.

J Exp Clin Cancer Res. 2012 Jan 12;31:4. doi: 10.1186/1756-9966-31-4.

30.

Reducing the risk of overdiagnosis in lung cancer: a support from molecular biology.

Barba M, Felsani A, Rinaldi M, Giunta S, Malorni W, Paggi MG.

J Cell Physiol. 2011 Sep;226(9):2213-4. doi: 10.1002/jcp.22558.

PMID:
21660943
31.

Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection.

Arisi I, D'Onofrio M, Brandi R, Felsani A, Capsoni S, Drovandi G, Felici G, Weitschek E, Bertolazzi P, Cattaneo A.

J Alzheimers Dis. 2011;24(4):721-38. doi: 10.3233/JAD-2011-101881.

PMID:
21321390
32.

Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer.

Natoli M, Leoni BD, D'Agnano I, D'Onofrio M, Brandi R, Arisi I, Zucco F, Felsani A.

J Cell Physiol. 2011 Jun;226(6):1531-43. doi: 10.1002/jcp.22487.

PMID:
20945374
33.

Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways.

Casalbore P, Barone I, Felsani A, D'Agnano I, Michetti F, Maira G, Cenciarelli C.

J Cell Physiol. 2010 Sep;224(3):710-21. doi: 10.1002/jcp.22170.

PMID:
20432466
34.

Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer.

Mattarocci S, Abbruzzese C, Mileo AM, Visca P, Antoniani B, Alessandrini G, Facciolo F, Felsani A, Radulescu RT, Paggi MG.

J Cell Physiol. 2009 Dec;221(3):766-70. doi: 10.1002/jcp.21916.

PMID:
19688775
35.

Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice.

D'Onofrio M, Arisi I, Brandi R, Di Mambro A, Felsani A, Capsoni S, Cattaneo A.

Neurobiol Aging. 2011 Jun;32(6):1007-22. doi: 10.1016/j.neurobiolaging.2009.05.023. Epub 2009 Jul 14.

PMID:
19604602
36.

Mechanisms of defence from Fe(II) toxicity in human intestinal Caco-2 cells.

Natoli M, Felsani A, Ferruzza S, Sambuy Y, Canali R, Scarino ML.

Toxicol In Vitro. 2009 Dec;23(8):1510-5. doi: 10.1016/j.tiv.2009.06.016. Epub 2009 Jun 18.

PMID:
19540330
37.

MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.

Gatti G, Maresca G, Natoli M, Florenzano F, Nicolin A, Felsani A, D'Agnano I.

PLoS One. 2009;4(5):e5442. doi: 10.1371/journal.pone.0005442. Epub 2009 May 6.

38.

pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation.

De Santa F, Albini S, Mezzaroma E, Baron L, Felsani A, Caruso M.

Mol Cell Biol. 2007 Oct;27(20):7248-65. Epub 2007 Aug 20.

39.

New technologies used in the study of human melanoma.

Felsani A, Mileo AM, Maresca V, Picardo M, Paggi MG.

Int Rev Cytol. 2007;261:247-86. Review.

PMID:
17560284
40.

Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.

D'Agnano I, Valentini A, Gatti G, Chersi A, Felsani A.

J Cell Physiol. 2007 Jan;210(1):72-80.

PMID:
16998799
41.

Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins.

Felsani A, Mileo AM, Paggi MG.

Oncogene. 2006 Aug 28;25(38):5277-85. Review.

PMID:
16936748
42.

Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.

Bucci B, D'Agnano I, Amendola D, Citti A, Raza GH, Miceli R, De Paula U, Marchese R, Albini S, Felsani A, Brunetti E, Vecchione A.

Clin Cancer Res. 2005 Apr 1;11(7):2756-67.

43.

In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.

Noonan DM, Severino A, Morini M, Tritarelli A, Manente L, D'Agnano I, Starace G, Baldi A, Lombardi D, Albini A, Felsani A, Paggi MG.

J Cell Physiol. 2005 Mar;202(3):922-8.

PMID:
15389561
44.

Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts.

Kataoka Y, Matsumura I, Ezoe S, Nakata S, Takigawa E, Sato Y, Kawasaki A, Yokota T, Nakajima K, Felsani A, Kanakura Y.

J Biol Chem. 2003 Nov 7;278(45):44178-87. Epub 2003 Aug 28.

45.

Growth control by the retinoblastoma gene family.

Paggi MG, Felsani A, Giordano A.

Methods Mol Biol. 2003;222:3-19. No abstract available.

PMID:
12710677
46.

Identification of genes down-regulated during melanoma progression: a cDNA array study.

Baldi A, Battista T, De Luca A, Santini D, Rossiello L, Baldi F, Natali PG, Lombardi D, Picardo M, Felsani A, Paggi MG.

Exp Dermatol. 2003 Apr;12(2):213-8.

PMID:
12702151
47.

MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway.

Magenta A, Cenciarelli C, De Santa F, Fuschi P, Martelli F, Caruso M, Felsani A.

Mol Cell Biol. 2003 Apr;23(8):2893-906.

48.

The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells.

Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F, Catricalà C, Amantea A, Noonan DM, Albini A, Natali PG, Lombardi D, Paggi MG.

Oncogene. 2002 Sep 26;21(43):6684-8.

49.

Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.

D'Agnano I, Valentini A, Fornari C, Bucci B, Starace G, Felsani A, Citro G.

Oncogene. 2001 May 17;20(22):2814-25.

50.

The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation.

Paggi MG, Bonetto F, Severino A, Baldi A, Battista T, Bucci F, Felsani A, Lombardi D, Giordano A.

Oncogene. 2001 May 3;20(20):2570-8.

Supplemental Content

Loading ...
Support Center